Hyper-personalized AI-based AID SystemHyper-personalized AI-based AID System

In the realm of diabetes management, individuals living with type 1 diabetes (T1D) face a persistent challenge: the fluctuating nature of blood glucose levels and the constant need for precise insulin dosing. In type 1 diabetes, the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas, leading to an inability to produce insulin—a hormone essential for regulating blood sugar levels. Without insulin, glucose levels in the blood can rise to dangerous levels, causing a range of acute and chronic complications, including cardiovascular disease, kidney failure, nerve damage, and vision problems.

Insulin therapy is the cornerstone of type 1 diabetes management, aimed at replacing the deficient insulin and keeping blood glucose within a healthy range. However, achieving optimal glycemic control with manual insulin administration is a complex and demanding task. Factors such as diet, physical activity, stress, illness, and hormonal fluctuations can all influence blood glucose levels, requiring frequent adjustments in insulin dosage throughout the day.

AID (automated insulin delivery) systems offer a transformative solution by automating aspects of insulin delivery and glucose monitoring. These systems typically consist of a continuous glucose monitor (CGM) to measure glucose levels in real time and an insulin pump to deliver insulin doses as needed. By integrating these components with sophisticated algorithms, AID systems can adjust insulin delivery in response to changing glucose levels, mimicking the function of a healthy pancreas more closely.

However, existing AID systems often lack the level of personalization needed to effectively address the diverse physiological and lifestyle factors influencing blood glucose dynamics (such as dietary patterns, physical activity, stress levels, sleep patterns, alcohol consumption, medications, illnesses and infections). As a result, patients may struggle to achieve stable glycemic control, leading to frustration, anxiety, and an increased burden of disease management.

In this context, the integration of Artificial Intelligence (AI) holds immense promise, offering a pathway towards the development of hyper-personalized algorithms capable of revolutionizing AID technology by personalizing insulin delivery, implementing predictive analytics, leveraging adaptive learning and integrating other components (such as wearables) of the broader digital health ecosystem, hence transforming the lives of individuals living with diabetes.

The Hyper-Personalized AID System Use Case

One of the flagship research projects supported by DiabetesDAO involves the development of an AI-driven Automated Insulin Delivery (AID) system. This hyper-personalized system integrates continuous glucose monitoring, insulin dosing adjustments, and real-time user feedback. The goal is to create an adaptive insulin management system that optimizes treatment on an individual basis, improving time-in-range (TIR) and reducing complications.

The system functions by continuously analyzing a person's glucose levels, lifestyle factors, and historical insulin response data, allowing for precise, real-time adjustments in insulin dosing. By utilizing advanced machine learning models, the system can anticipate fluctuations and make proactive interventions, significantly reducing the risk of hypo- and hyperglycemic events.

A key advantage of this system is its integration with wearable technology, such as smart insulin pumps and continuous glucose monitors (CGMs), sleep, stress and activity trackers.

DiabetesDAO has engaged Welshare Health to build the technical infrastructure for DiabetesDAO's efforts to collect community-driven health data for its research purposes, including the development of these hyper-personalized AID systems in exchange for a service development fee.

This initiative represents a groundbreaking shift in diabetes care, providing an efficient, scalable, and individualized approach to insulin management. By funding this project, DiabetesDAO aims to revolutionize diabetes treatment through AI-driven automation, ultimately improving quality of life for millions of people worldwide.